Retraction Note: CD276 enhances sunitinib resistance in clear cell renal cell carcinoma by promoting DNA damage repair and activation of FAK-MAPK signaling pathway

Lignende værker

• CD276 is a promising biomarker for the prognosis of clear cell renal cell carcinoma
  af: Yan‐Hang Yu, et al.
  Udgivet: (2024-10-01)
• A multimodal deep learning framework for predicting sunitinib response in advanced clear cell renal cell carcinoma
  af: Xi Tian, et al.
  Udgivet: (2026-02-01)
• CYP1B1 promotes angiogenesis and sunitinib resistance in clear cell renal cell carcinoma via USP5-mediated HIF2α deubiquitination
  af: Ke Ma, et al.
  Udgivet: (2025-08-01)
• AUY922 improves sensitivity to sunitinib in clear cell renal cell carcinoma based on network pharmacology and in vitro experiments
  af: Zixuan Chen, et al.
  Udgivet: (2024-07-01)
• Clear Cell Renal Cell Carcinoma, Diagnostic and Therapeutic Difficulties, Case Report and Literature Review
  af: Weronika Stolpa, et al.
  Udgivet: (2022-09-01)